InvestorsHub Logo
Followers 8
Posts 884
Boards Moderated 0
Alias Born 04/18/2020

Re: None

Tuesday, 09/29/2020 5:39:12 PM

Tuesday, September 29, 2020 5:39:12 PM

Post# of 8343
Reading today’s news several times. Why is it bad news? It could be but maybe not
The study was supposed to be 470 patients.they signed up 503.
The independent data monitoring committee recommended adding 210 patients. They already have 33 extra so they would have to add 177 more. This was a non binding recommendation. The company rejected this recommendation.
Does this mean that they don’t have enough money or that they don’t want to take the extra time or do they just think that patients signed up during Covid will not do as well?

Tonix “remains blinded to the interim results.” They plan to continue the study with the 503 patients and report results in 4th quarter 2020 which starts in 2 days.

They believe they have a winner for fibromyalgia. I am an MD and I can tell you that these patients are very difficult to treat. Many get addicted to opiates and kill themselves either accidentally or on purpose. Cymbalta is an antidepressant that causes weight gain and erectile dysfunction. Your pain gets better but you become obese and can’t have sex.
Lyrica and Neurontin cause sedation and don’t really help as much as opiates.
I think Seth knows he has a winner and wants to get his drug on the market ASAP
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TNXP News